Your browser doesn't support javascript.
SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues.
Baay, Marc; Neels, Pieter.
  • Baay M; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium. Electronic address: marc.baay@p-95.com.
  • Neels P; International Alliance for Biological Standardization - IABS, Geneva, Switzerland. Electronic address: Pieter.neels@vaccine-advice.be.
Biologicals ; 67: 69-74, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-712934
ABSTRACT
This second International Alliance for Biological Standardization COVID-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable participation from low- and middle-income countries, to discuss the use of controlled human infection models to accelerate development and market authorization assessment of a vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Pandemics / Betacoronavirus / Drug Development / Human Experimentation Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Biologicals Journal subject: Allergy and Immunology Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Pandemics / Betacoronavirus / Drug Development / Human Experimentation Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Biologicals Journal subject: Allergy and Immunology Year: 2020 Document Type: Article